Inspire Medical Systems, Inc. has announced an accelerated share repurchase (ASR) transaction under an agreement with Goldman Sachs & Co. LLC to repurchase an aggregate of $75.0 million of shares of the Company’s common stock. The ASR transaction is scheduled to terminate in the first quarter of 2025.
Company Information
Company
Inspire Medical Systems
Location
Minneapolis, Minnesota, United States
About
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company's proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.